OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 92 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 13.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $285,000 | – | 15,421 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cloverdale Capital Management, LLC | 324,722 | $6,170,000 | 3.39% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1,233,589 | $23,437,000 | 0.77% |
| Beryl Capital Management LLC | 220,189 | $4,184,000 | 0.77% |
| BERKLEY W R CORP | 109,601 | $2,082,000 | 0.44% |
| WATER ISLAND CAPITAL LLC | 514,970 | $9,784,000 | 0.27% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 91,411 | $1,737,000 | 0.22% |
| DELTEC ASSET MANAGEMENT LLC | 50,000 | $950,000 | 0.21% |
| Versor Investments LP | 113,905 | $2,164,000 | 0.21% |
| ALGERT GLOBAL LLC | 14,774 | $281,000 | 0.16% |
| Hillsdale Investment Management Inc. | 92,941 | $1,766,000 | 0.16% |